Kyri van Hoose
Director of Finance/CFO bij DERMATA THERAPEUTICS, INC.
Vermogen: - $ op 31-03-2024
Profiel
Kyri K.
van Hoose is currently the Vice President-Accounting at Turning Point Therapeutics, Inc. and the Chief Financial Officer & Senior Vice President at Dermata Therapeutics, Inc. Previously, Kyri held the position of Corporate Controller & Senior Director-Finance at ACADIA Pharmaceuticals, Inc. from 2005 to 2016.
In 2019 to 2020, Kyri was the Head-Finance at Curzion Pharmaceuticals, Inc. and from 2020 to 2021, Kyri served as the Chief Financial Officer at TEGA Therapeutics, Inc. Kyri completed an undergraduate degree at the University of Southern California in 2000 and obtained an MBA from the University of California, Irvine in 2005.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
04-01-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Kyri van Hoose
Bedrijven | Functie | Begin |
---|---|---|
TURG POIN | Comptroller/Controller/Auditor | 05-05-2021 |
DERMATA THERAPEUTICS, INC. | Director of Finance/CFO | 01-09-2021 |
Eerdere bekende functies van Kyri van Hoose
Bedrijven | Functie | Einde |
---|---|---|
TEGA Therapeutics, Inc.
TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Director of Finance/CFO | 30-04-2021 |
Curzion Pharmaceuticals, Inc.
Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-04-2020 |
ACADIA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01-02-2016 |
Opleiding van Kyri van Hoose
University of Southern California | Undergraduate Degree |
University of California, Irvine | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ACADIA PHARMACEUTICALS INC. | Health Technology |
DERMATA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Curzion Pharmaceuticals, Inc.
Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Health Technology |
TEGA Therapeutics, Inc.
TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Health Technology |